stockrowMedline Inc.
MDLN Healthcare Medical Instruments & Supplies
Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.
- Revenue
- +14.1%
- Free cash flow
- +916.1%
- Total debt
- −23.7%
Quarter to September 2026, against a year earlier
Follow MDLN
Alert me
Medline Inc. (MDLN) Return on equity
Medline Inc.'s return on equity over the twelve months to 30 September 2026 was 3.18%, down 3.4 percentage points from fiscal 2025 (6.54%). That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 6.54% | 6.54 |
| FY2024 | 0.00% | 0.00 |
| FY2023 | 0.00% | — |
Return on equity against peers
| Company | Return on equity |
|---|---|
| RMD ResMed Inc. compare | 26.4% |
| WST West Pharmaceutical Services, Inc. compare | 21.2% |
| ISRG Intuitive Surgical, Inc. compare | 17.8% |
| COO The Cooper Companies, Inc. compare | 6.84% |
| BDX Becton, Dickinson and Company compare | 3.77% |
| SOLV Solventum Corporation compare | 3.19% |
| MDLN Medline Inc. | 3.18% |
| ALC Alcon compare | 2.94% |
| BAX Baxter International Inc. compare | −10.6% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on MDLN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Book value per share
- The full statement